Young Investigator Award

The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this research grant is to fund physicians during the transition from a fellowship program to a faculty appointment.

The Young Investigator Award (YIA) is a one-year research grant totaling $50,000, paid in two increments to the awardee’s institution. The applicant must be a physician (MD, DO, or international equivalent) who is currently within the last two years of his/her final subspecialty training at an academic medical institution at the time of grant submission. Applicants should be planning an investigative career in clinical oncology.

Applications for the 2013 YIA are now closed.  Read the most recent Request for Proposals (RFP) for eligibility criteria and detailed instructions for submitting an application.

Applications for the 2014 YIA are expected to open July 1, 2013.  Please check this website at that time for the RFP

The 2013 YIAs are supported by:

AbbVie, Inc.
American Association for Cancer Research
Amgen
Astellas Pharma US Inc.
The Breast Cancer Research Foundation
Celgene Corporation (2)
The Cholangiocarcinoma Foundation
McHenry and Lisa Tichenor Fund of Communities Foundation of Texas
Daiichi Sankyo, Inc. (2)
Don Shula Foundation, Inc.
Eisai Inc. (2)
Florida Society of Clinical Oncology
Genentech BioOncology™ (5)
Gilead Sciences Inc.

GlaxosmithKline (3)
Janssen Biotech, Inc.
Journal of Clinical Oncology
Kidney Cancer Association
Lilly USA, LLC.
Merck Oncology
Millennium: The Takeda Oncology Company (2)
Novartis Oncology
Onyx Pharmaceuticals, Inc.
Pfizer Oncology
Roche
Strike 3 Foundation (2)
WWWW Foundation, Inc. (QuadW)




ENDOWMENT FUND DONORS

Evelyn H. Lauder Young Investigator Award
Endowment Fund


The Sally Gordon Young
Investigator Award Endowment Fund

The John R. Durant, MD, Young Investigator Award
Endowment Fund